Rhenman & Partners Asset Management AB Has $3.30 Million Position in Inspire Medical Systems, Inc. $INSP

Rhenman & Partners Asset Management AB reduced its stake in Inspire Medical Systems, Inc. (NYSE:INSP) by 41.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 35,800 shares of the company’s stock after selling 25,200 shares during the period. Rhenman & Partners Asset Management AB owned about 0.12% of Inspire Medical Systems worth $3,302,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Royal Bank of Canada raised its holdings in Inspire Medical Systems by 16.0% in the 1st quarter. Royal Bank of Canada now owns 32,769 shares of the company’s stock valued at $5,220,000 after buying an additional 4,528 shares during the last quarter. Integrated Wealth Concepts LLC bought a new position in Inspire Medical Systems in the 1st quarter valued at approximately $524,000. Goldman Sachs Group Inc. raised its holdings in Inspire Medical Systems by 57.9% in the 1st quarter. Goldman Sachs Group Inc. now owns 51,422 shares of the company’s stock valued at $8,190,000 after buying an additional 18,857 shares during the last quarter. Marshall Wace LLP raised its holdings in Inspire Medical Systems by 3.8% in the 2nd quarter. Marshall Wace LLP now owns 15,905 shares of the company’s stock valued at $2,064,000 after buying an additional 577 shares during the last quarter. Finally, Jump Financial LLC bought a new position in Inspire Medical Systems in the 2nd quarter valued at approximately $931,000. 94.91% of the stock is currently owned by institutional investors and hedge funds.

Inspire Medical Systems Stock Performance

Inspire Medical Systems stock opened at $42.74 on Friday. Inspire Medical Systems, Inc. has a 52-week low of $38.91 and a 52-week high of $147.03. The firm has a 50 day moving average price of $48.05 and a two-hundred day moving average price of $71.79. The firm has a market cap of $1.23 billion, a price-to-earnings ratio of 9.52, a PEG ratio of 4.38 and a beta of 0.73.

Inspire Medical Systems (NYSE:INSP) last released its quarterly earnings results on Monday, May 4th. The company reported $0.10 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.28) by $0.38. Inspire Medical Systems had a net margin of 14.33% and a return on equity of 10.35%. The firm had revenue of $204.58 million during the quarter, compared to analyst estimates of $200.04 million. During the same quarter last year, the business earned $0.10 EPS. The company’s revenue was up 1.6% compared to the same quarter last year. Inspire Medical Systems has set its FY 2026 guidance at 0.750-1.250 EPS. As a group, equities research analysts predict that Inspire Medical Systems, Inc. will post 0.91 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research analysts recently issued reports on INSP shares. Morgan Stanley set a $60.00 price objective on shares of Inspire Medical Systems in a report on Wednesday, February 18th. Robert W. Baird dropped their price objective on shares of Inspire Medical Systems from $63.00 to $50.00 and set a “neutral” rating for the company in a report on Tuesday, May 5th. Weiss Ratings lowered shares of Inspire Medical Systems from a “sell (d+)” rating to a “sell (d)” rating in a report on Wednesday, May 6th. Mizuho dropped their price objective on shares of Inspire Medical Systems from $70.00 to $55.00 and set an “outperform” rating for the company in a report on Tuesday, May 5th. Finally, Evercore set a $55.00 price objective on shares of Inspire Medical Systems in a report on Tuesday, May 5th. Four analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $81.84.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.